跳至主要内容
临床试验/JPRN-UMIN000018172
JPRN-UMIN000018172已完成未知

attitude towards Food consumption in AD patients Revive with RIVastigmine Effects - Food-ARRIVE study

Kagawa University Hospital0 个研究点目标入组 50 人开始时间: 2015年7月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fall into any of the following criteria are excluded from this study: 1) Patients with a history of hypersensitivity to components of rivastigmine or to carbamate derivative 2) Patients with physical disabilities which interfere their food intake 3) Patients with life threating disease such as malignancy, pneumonia, etc. 4) Patients with a gastrointestinal disorder 5) Patients with conditions that are judged by physicians to be inappropriate to this study 6) Patients who need to start, or continue to use donepezil hydrochloride (drugs for dementia of Alzheimer type and Levy body), or galantamine hydrobromide (drug for dementia of Alzheimer type)

研究者

相似试验